SLC25A24P2

Across TCGA pan-cancer cohorts, SLC25A24P2 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of SLC25A24P2’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where SLC25A24P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types SLC25A24P2 is over-expressed in tumor.

BRCA, BLCA, and HNSC are the cancer types where SLC25A24P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC25A24P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	III,IV	+1.296	<.001	6	view →
BLCA	Male	All	+0.611	.046	2	view →
HNSC	Male	II,III,IV	+0.067	.047	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

SLC25A24P2–BRCA

Open the BRCA breakdown →